Monday 13 July – Monday 20 July Victoria’s drop in breast cancer reporting has been published in regional and metro media outlets. Advocate groups urge people to see their doctor if any cancer symptoms present. Researchers presenting at the European Association of Urology provided insights into diagnosis, treatment and prevention of prostate cancer, including a gene associated with an aggressive form of the disease, a new pair of agents that show effectiveness for precision diagnosis and treatment, and a ‘highly likely’ link with the human papillomavirus. A single global methodology has been developed, using the Active Surveillance prostate cancer database, to identify which patients with prostate cancer are at risk of the disease developing and which patients can continue to safely delay treatment. |
| | | Prostate Cancer |  |  | The Medical News • Jul 20, 2020 6:29 |  | | You have been diagnosed with prostate cancer and your doctor gives you the option of not being treated, but of remaining under observation... How to decide whether or not to start treatment for prostate cancer? |
|
| | Science Media Exchange - Scimex • Jul 17, 2020 11:58 | | | Researchers presenting at the European Association of Urology congress suggest that they have found a switch that is associated with ... the tumour is pushing outside of the prostate). Malignant cancer: A tumour becomes malignant when it spreads outside the... |
|
| | The Australian • Jul 14, 2020 19:23 | | | Some prostate cancers are “highly likely” to be caused by human papillomavirus, according to a review of research. HPV is a common... |
|
| | Proactive Investors Australia • Jul 14, 2020 12:47 | | | This permit enables the company to proceed with its botanical research projects in collaboration with Royal Melbourne Institute of ... MGC Pharmaceuticals granted permit to continue cannabis botanical and cancer research projects |
|
| | The Medical News • Jul 14, 2020 11:25 | | | Researchers have developed a new pair of agents that show exceptional effectiveness for precision diagnosis and treatment of prostate ... New theranostic agents show efficacy for precision diagnosis, treatment of prostate cancer |
|
|
| | | Cancer and COVID-19 | | | Shepparton News • Jul 18, 2020 19:15 | | | Greater Shepparton residents are being reminded to visit their doctor about concerns or body changes after new data revealed a concerning ... Drop in breast cancer reporting |
|
| | Sky News Australia • Jul 18, 2020 14:12 | | | Cancer Council Australia has reported a 37 per cent drop in the number of breast cancer diagnoses alone since the outset of the coronavirus... Cancer diagnoses drop amid 'COVID-19 fear and anxiety' |
|
| | The Australian • Jul 17, 2020 18:47 | | | A researcher works on virus replication in order to develop a vaccine against COVID-19. Picture: AFP Australia’s researchers have warned... |
|
| | ABC News • Jul 10, 2020 21:18 | | | As Australians collectively hunkered down to flatten the coronavirus curve in March, Emma Harper was fighting a very personal battle. The ... explain the extent of the decrease. The director of the Victorian Comprehensive Cancer Centre's breast service, oncologist Bruce ... |
|
|
| | | Targeted Therapies | | | Science Media Exchange - Scimex • Jul 17, 2020 12:29 | | | The most well-known breast and ovarian cancer-causing genes are BRCA1 and BRCA2, and international researchers, including an Aussie, ... University, Kolkata (India); Tata Medical Centre, Kolkata (India); University of Melbourne, Victoria (Australia); Newcastle ... |
|
| | The Medical News • Jul 16, 2020 15:16 | | | A pioneering lung cancer study, led by the University of Birmingham's Cancer Research UK Clinical Trials Unit, has highlighted important ... A pioneering lung cancer study, led by the University of Birmingham's Cancer Research UK Clinical Trials Unit, ... |
|
| | The Medical News • Jul 16, 2020 9:47 | | | In a clinical trial evaluating a novel immunotherapy option for cancer treatment, a child with rhabdomyosarcoma, a form of muscle cancer, ... In a clinical trial evaluating a novel immunotherapy option for cancer treatment, a child with rhabdomyosarcoma, a form ... |
|
| | MSN - Australia • Jul 14, 2020 15:24 | | | Roche inks deal with Blueprint worth up to $1.7 billion for cancer drug Roche inks deal with Blueprint worth up to $1.7 billion for cancer drug |
|
| | Oncology News Australia • Jul 13, 2020 23:30 | | | Natural killer (NK) cells, a type of immune cell, are known to limit metastasis by inducing the death of cancer cells. But metastases still... Breast cancer cells can reprogram immune cells to assist in metastasis |
|
|
|
|
|
|
